Ozempic Copies to Cost $14 in India as Generic GLP-1 Era Starts
At least a dozen large drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires Friday. Source link
